Bridgeway Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $111K | Hold |
|
|||||
|
2024
Q2 | $266K | Hold |
|
|||||
|
2024
Q1 | $276K | Buy |
|
|||||
|
2023
Q4 | $308K | Hold |
|
|||||
|
2023
Q3 | $156K | Hold |
|
|||||
|
2023
Q2 | $124K | Sell |
|
|||||
|
2023
Q1 | $132K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $91K | Sell |
|
|||||
|
2022
Q1 | $202K | Hold |
|
|||||
|
2021
Q4 | $554K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $230K | Hold |
|
|||||
|
2019
Q3 | $346K | Hold |
|
|||||
|
2019
Q2 | $308K | Sell |
|
|||||
|
2019
Q1 | $670K | Buy |
|
|||||
|
2018
Q4 | $367K | Sell |
|
|||||
|
2018
Q3 | $1.02M | Hold |
|
|||||
|
2018
Q2 | $877K | Sell |
|
|||||
|
2018
Q1 | $1.29M | Buy |
|